Episode
GLP-1 RAs and Hair Loss—Evaluating and Managing a Potential Side Effect - Frankly Speaking Ep 478
- Published
- Mar 30, 2026
- Duration seconds
- 572
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/frankly-speaking-about-family-medicine-434006/episodes/glp-1-ras-and-hair-loss-evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/glp-1-ras-and-hair-loss-evaluating-and-managing-a-potential-side-effect-frankly-speaking-ep-478.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-478 Overview: As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) become increasingly common in managing obesity, it is important for clinicians to recognize lesser-known adverse effects. This episode highlights the potential link between GLP-1 RAs and alopecia, equipping you to better evaluate, counsel, and manage patients reporting hair loss. Episode resource links: Alsuwailem OA, Alanazi R, Almutairi HM, Asiree RH, Almutairi W, Almutairi TM, Zamandar A, Alkhames S. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. Cureus. 2025 Sep 16;17(9):e92454. Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at [email protected] The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.